The acetaminophen market is fragmented with the presence of a large number of small and medium-sized manufacturers. Key Players In The Acetaminophen Market Include GlaxoSmithKline Pharmaceuticals Ltd., Angene International Limited, Mallinckrodt Pharmaceuticals Granules India Ltd., Sigma-Aldrich Co. LLC, Farmson Pharmaceutical Gujarat Pvt. Ltd., Cipla, Granules India Limited, and BOC Sciences. The report offers a detailed competitive analysis of the key players in the acetaminophen market, with their company profiles, recent developments, and key market strategies.
Acetaminophen, also known as paracetamol or APAP, is a pain reliever and temperature reducer. Usually, it is used to relieve mild to moderate pain. Acetaminophen is generally considered safe when used as directed. However, it can cause serious liver damage if too much is taken.
The global acetaminophen market is growing at a rapid pace. The major factors driving the growth of this market are the increasing consumption of acetaminophen and the growing demand for acetaminophen-based products. Additionally, the rise in the number of patients suffering from chronic pain is one of the other major factors driving the growth of the acetaminophen market.
According to recent studies published by the global research hub, the acetaminophen (Paracetamol) market was valued at USD 1099.5 million in 2021 and is supposed to reach a value of USD 1,432.6 million by the year 2028. The global market is projected to grow at a compound annual growth rate (CAGR) of 4.8% during the forecast period.
Major Companies in the Acetaminophen (Paracetamol) Market are as follows:
Sigma-Aldrich Co. LLC, an American multinational company, is headquartered in St. Louis, Missouri, U.S. It was founded in 1975 by the merger of Sigma Chemical Company and Aldrich Chemical Company. Sigma-Aldrich grew through various acquisitions and has operations in approximately 40 countries.
Sigma-Aldrich Co., LLC, serves the chemical, life sciences, and biotechnology sectors with analytical instruments, lab equipment, and specialty diagnostics that provide rapid and accurate results for customers in research, clinical, and applied markets. Since Sigma-Aldrich Co. LLC. was acquired by Merck KGaA in November 2015, the data used for financial reports is for Merck & Co., Inc.
Merck & Co. annual revenue for 2021 was USD 48.7 billion
Angene International Limited is a chemical company that offers quality specialty chemicals for use in research and development and commercial manufacturing. The company offers over 100,000 products, including lab reagents, intermediates, bulk commodities, agrochemicals, natural ingredients, and active pharmaceutical ingredients (APIs). Angene International Limited has manufacturing facilities in the Americas, Europe, and Asia.
The company is primarily engaged in a global business that develops, manufactures, markets, and distributes branded and generic specialty pharmaceutical products and therapies. Mallinckrodt Pharmaceuticals operates its business in two reportable segments, which are further described as specialty brands, which produce and market branded pharmaceutical products and therapies; and specialty generics, which produce and market specialty generic pharmaceuticals and active pharmaceutical ingredients consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen, and other active ingredients.
Granules India Ltd. is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad, India. The company is primarily engaged in the manufacture, research, and development of active pharmaceutical ingredients. The company also distributes pharmaceutical formulation intermediates and finished dosages to quality-conscious customers in both regulated and semi-regulated markets. The company is dedicated to excellence in manufacturing, quality, and customer service. Granules India Ltd. has eight manufacturing sites with a global presence in more than 75 countries. The company has the largest PFI facility in the world. Currently, over 2,000 employees from all over the world work in granules in India. Granules also offer all three components of the pharmaceutical value chain, which gives customers flexibility and choice.
Founded in 1969, Farmson Pharmaceutical Gujarat Pvt. Ltd. is an Indian based pharmaceutical manufacturing company that pioneered the production of paracetamol and acetaminophen in India. The company manufactures paracetamol using indigenous technology, and what emerged was an innovative route to produce an international-quality product with unmatched quality and consistency. At present, Farmson is India's largest manufacturer of paracetamol and acetaminophen. The company's growth is fuelled by its excellence in quality and exemplary service capabilities. Farmson has a global presence in the U.S., U.K., France, Germany, Spain, Australia, Sri Lanka, and various other countries in the Middle East and Africa. Farmson's unique combination of high-volume capability, cutting-edge technology, and expertise enables it to meet the ever-challenging, expectations and growing demands of its customers, both in the domestic market and globally.
BOC Sciences is an American multinational company and a brand of BOCSCI Inc., which was founded in 2005. It is headquartered in Shirley, New York, USA. BOC Sciences provides business in sectors such as development, manufacturing, marketing, and distribution of premium chemicals. BOC Sciences provides a wide range of bulk compounds and specialty species for the pharmaceutical, agrochemical, and biotechnology industries. Also, BOC Sciences offers support to the pharmaceutical industry in all stages of drug discovery and analytical services. BOC Sciences produces raw materials, registered GMP starting materials, and intermediates in small to large quantities.
GlaxoSmithKline plc is a British pharmaceutical company headquartered in Brentford, London, and was founded in 2000 by a merger of GlaxoWellcome and SmithKline Beecham. GSK is a science led global healthcare company that researches and develops a broad range of innovative products. GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products worldwide, including vaccines, over the counter medicines, and health related consumer products. The company operates through five segments: global pharmaceuticals, HIV, pharmaceutical R&D, vaccines, and consumer healthcare. The company has a significant global presence with commercial operations in more than 150 countries, a network of 89 manufacturing sites in 36 countries, and large R&D centers in Europe, North America, and Asia.
GSK annual revenue for 2021 was USD 46.91 billion, a 7.14% rise from 2020.